Periostat and Mediastinal mass - a phase IV clinical study of FDA data

Summary:

Mediastinal mass is reported as a side effect among people who take Periostat (doxycycline hyclate), especially for people who are female, 60+ old, also take Lorazepam, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Mediastinal mass when taking Periostat. It is created by eHealthMe based on reports of 263 people who have side effects when taking Periostat from the FDA, and is updated regularly.

What is Periostat?

Periostat has active ingredients of doxycycline hyclate. eHealthMe is studying from 273 Periostat users. Check the latest studies of Periostat.

What is Mediastinal mass?

Mediastinal mass (mass in the part of the chest that separates the lungs) is found to be associated with 110 drugs and 170 conditions by eHealthMe. Check the latest studies of Mediastinal mass.



On Jul, 19, 2026

263 people reported to have side effects when taking Periostat.
Among them, 16 people (6.08%) have Mediastinal mass.

Could Periostat cause Mediastinal mass?

Among these 16 people:

What is the gender of people who have Mediastinal mass when taking Periostat? *

  • female: 93.75 %
  • male: 6.25 %

What is the age of people who have Mediastinal mass when taking Periostat? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

What are other drugs people take besides Periostat? *

  1. Zometa: 16 people, 100.00%
  2. Metronidazole: 16 people, 100.00%
  3. Alphagan: 16 people, 100.00%
  4. Arimidex: 16 people, 100.00%
  5. Avastin: 16 people, 100.00%
  6. Cephalexin: 16 people, 100.00%
  7. Cosopt: 16 people, 100.00%
  8. Lipitor: 16 people, 100.00%
  9. Lopressor: 16 people, 100.00%
  10. Lorazepam: 16 people, 100.00%

What are other side effects people have besides Mediastinal mass? *

  1. Weight Decreased: 16 people, 100.00%
  2. Joint Pain: 16 people, 100.00%
  3. Osteolysis (dissolution of bone): 16 people, 100.00%
  4. Oesophageal Obstruction (blockage of oesophagus): 16 people, 100.00%
  5. Oesophageal Food Impaction (blockage of oesophagus by food): 16 people, 100.00%
  6. Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 16 people, 100.00%
  7. Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 16 people, 100.00%
  8. Lymphoma (cancer that begins in immune system cells): 16 people, 100.00%
  9. Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 16 people, 100.00%
  10. Visual Impairment: 16 people, 100.00%

What are the existing conditions these people have? *

  1. Breast Cancer Metastatic: 16 people, 100.00%
  2. Gastroesophageal Cancer: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Periostat and have Mediastinal mass?

- Check whether Mediastinal mass is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Periostat:

Mediastinal mass treatments and more:

How severe was Mediastinal mass and when was it recovered:

Expand to all the drugs that have ingredients of doxycycline hyclate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Periostat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Mediastinal mass:

Browse all the conditions that are associated with Mediastinal mass:


How the study uses the data?

The study uses data from the FDA. It is based on doxycycline hyclate (the active ingredients of Periostat) and Periostat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: